期刊文献+

原发性肝癌血清磷脂酶A_2活性变化及临床意义 被引量:1

The Change of Serum Phospholipase A_2 Activity and its Clinical Significance in Patient with Primary Liver Cancer
暂未订购
导出
摘要 目的 探讨原发性肝癌(PLC)患者血清磷脂酶A2活性的变化及临床意义。方法 采用[^3H]-油酸标记生物膜法检测了60例PLC患者(其中Ⅰ、Ⅱ、Ⅲ期肝癌患者分别为14例、23例、23例)以及16例手术切除肿瘤后和19例肝动脉栓塞化疗后患者血清PLA2的动态变化。结果 PLC患者血清PLA2活性29.27±4.15(%)明显高于对照组8.42±2.01(%); ObjectiveTo Study the change of serum Phospholipase A_2 activity and its clinical significance in patient with primary liver cancer. Methods: PLA_2 activity was determined in 60 patients with PLC and in 35 cases of them after hepatectomy or prechemtherapy by [H] - oletate ra- dioactivity. Results:PLA_2 activity in stage Ⅰ, Ⅱ, Ⅲ patients with PLC was significantly higher than that in control group(P <0. 05), the in- crease of PLA_2 activity was related with the clincal stage and the 1 - year survial rate PLA_2 activity decreased significantly after treatment by hepate- ctomy or prechemotherapy (P <0. 05). Conclusion: It is suggested that the level of PLA_2 activity may be considered as one of the serologic pa- rameter in diagnosis and classification of clinical stage of PLC, therefore,the activity of PLA_2 in serum of PLC Patients may be helpful for estimating the development of disease,the volume of the tumor, the curative affect and prognosis of the patients with PLC.
出处 《重庆医学》 CAS CSCD 2000年第3期203-204,共2页 Chongqing medicine
关键词 原发性肝癌 磷脂酶A2 活性变化 Primary liver cancer Phospholipase A_2
  • 相关文献

参考文献6

  • 11,Ruff R, ChasenMR, Long JE, et al. A phase Ⅱ study of oral clofazimine in unresectable and metastasushepatocellular carcinoma. Anm Oncol, 1998,9(2):217~219
  • 22,Marki F, Franson R. Endogenous suppression of neutral-active and calcium-dependentphospholipse A2 in human poly morphonuclear leukocytes. Biochem Biophys Acta,1986, 879:149~156
  • 33,Yamashita SI, Ogawa M, Sakamotok, et al. Elevation of serum group Ⅱ phospholipase A2in patients with advanced cancer. Clinical Chimita Acta, 1994,228:91~99
  • 44,Yamashita S, Yamashita J, Sakamoto K, et al. Increased expression ofmembrane-associated phospholipase A2 shows malignant potential of human breastcancer cells. Cancer, 1993,71:3058~3064
  • 55,Ogawa M. Group Ⅱ phospholipase A2 in neoplastic disease. Prog Surg BaselKarger, 1997, 24:200~204
  • 66,Kjyohara H, Egami H, Kako H, et al. Immunohistochemical localization of group Ⅱphospholipase A2 in human pancreatic carcinoma. Int J Pacreatol, 1993,13:49~57

同被引文献16

  • 1Lhousseine T, Wu Yz. Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome [J]. Acta Pharmacol Sin, 2003, 24 (12): 1292-1296.
  • 2Murakami M, Shimbara S, Kambe T , et al. The functions of five distinct mammalian phospholipase A2 in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2 are functionally redundant and act in concert with eytosolic phospholipase A2[J]. Biol Chem , 1998, 273 (23): 14411-14423.
  • 3Kannel WB. Range of serum cholesterol values in the population developing coronary disease [J]. AM J Cardiol,1995,76(9): 69C-77C.
  • 4Keiji T ,Zenya I,Shigeki T, et al. The contribution of phospholipase A2 to the cochlear dysfunction induced by transient ischemia [J]. Hearing Research, 2000, 144(1) :1-7.
  • 5Li Y, Wang Y Detection of human papillomavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients [J]. Cancer Genet Cytogenet,2008,182 (1):12-17.
  • 6Nader R, Paul M. High -sensitivity C -reactive protein: a novel and promising marker of coronary heart disease[J].Clin Chem, 2001, 47(3):403-411.
  • 7Kennedy BP, Soravia C, Moffat J,et al. Overexpression of the nonpancreatic secretory group Ⅱ PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients [J]. Cancer Res,1998,58. (3): 500- 503.
  • 8Kashiwagi M, Friess H, Uhl W,et al, Group Ⅱ and Ⅳ phosphoiipase A (2) areproduced in human pancreatic cancer cells and influence prognosis[J]. Gut, 1999,45 (4):605-612.
  • 9Leung SY, Chen X, Chu KM, et al. Phospholipase A2 group IIA expression ingastric adenocarcinoma is associated with prolonged survival and less frequent metastasis[J]. Proc Nail Acad Sci USA, 2002, 99 (25) : 16203-16208.
  • 10Graff JR, Konicek BW, Deddens JA, et al. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade[J]. Clin Cancer Res,2001, 7 (12):.3857-3861.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部